$ROIV

2 theses

bullish 0%neutral 0%bearish 100%

Avg return (3m)

—

Win rate (3m)

— (0 resolved)

1d 3d 1w 1m 3m 6m 1y

Past performance does not predict future results. Informational only, not investment advice.

Recent theses

Prices as of Aug 24, 1:28 PM ET

$ROIVSEC Form 4bearish

Sukhatme Mayukh · President & CIO at Roivant Sciences Ltd. · 60d ago1 prior · awaiting results

Sold 335,174 @ $36.88 avg · $12,360,813 · 2026-08-19

Form 4: Sukhatme Mayukh sold ROIV

Sukhatme Mayukh (President & CIO at Roivant Sciences Ltd.) reported an open-market sale of 335,174 shares of ROIV at an average $36.88, roughly $12,360,813, in a Form 4 filed 2026-08-21.

At post $36.30Now $36.43+0.3% since postedas of Aug 24, 1:28 PM ET

1d—

3d+0.2%

1w-4.4%

1m+9.6%

3m—

6m—

1y—

View filing on SEC.gov →

$ROIVSEC Form 4bearish

Sukhatme Mayukh · President & CIO at Roivant Sciences Ltd. · 63d ago1 prior · awaiting results

Sold 664,826 @ $36.34 avg · $24,160,402 · 2026-08-14

Form 4: Sukhatme Mayukh sold ROIV

Sukhatme Mayukh (President & CIO at Roivant Sciences Ltd.) reported an open-market sale of 664,826 shares of ROIV at an average $36.34, roughly $24,160,402, in a Form 4 filed 2026-08-18.

At post $37.37Now $36.43-2.5% since postedas of Aug 24, 1:28 PM ET

1d+0.1%

3d-2.9%

1w-2.4%

1m+7.0%

3m—

6m—

1y—

View filing on SEC.gov →

End of results.